🇺🇸 FDA

Drug profile · INN

bretylium tosylate

BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

bretylium tosylate (BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN bretylium tosylate
Brand BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Route INJECTION
Formulation INJECTABLE

Frequently asked questions

What is bretylium tosylate?

bretylium tosylate (BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for bretylium tosylate?

BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER is a marketed brand name for bretylium tosylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of bretylium tosylate?

bretylium tosylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.